Bitcoin Records Rare Back-to-Back Quarterly Decline
BlockBeats News, June 28th. Bitcoin fell below $60,000 over the weekend, with a cumulative decline of about 7% in the past week. As the second quarter comes to a close, Bitcoin is expected to see a quarterly decline of around 12%, following a 22% decline in the first quarter, potentially setting a rare record of consecutive quarterly declines in history.
Meanwhile, altcoins have generally seen larger declines than Bitcoin. In the past week, Ethereum has fallen by about 9.5%, Dogecoin by 11.7%, HYPE by 10.6%, XRP by 8.7%, Solana by 3.5%, and TRON by approximately 1.5%.
Analysts believe that the continued pressure on the market is mainly influenced by multiple factors, including funds flowing into AI-driven semiconductor and storage chip sectors, continuous outflows from the U.S. spot Bitcoin ETF, the Fed maintaining a hawkish stance, and the U.S. Dollar Index holding at high levels. The market will pay attention to the third-quarter ETF fund flows and whether demand improves to assess whether the crypto market can break away from the weak trend seen in the first half of the year.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Blackstone (BX.US) injects up to $1.5 billion, providing fresh ammunition for Pfizer (PFE.US) in the weight-loss drug race
Pfizer announced on Wednesday that it has reached an agreement with Blackstone to obtain up to $1.5 billions in funding to support the development of its experimental monthly obesity treatment drug.
Bernstein Downgrades Nvidia Rating and Target Price

Google (GOOGL.US) DeepMind launches AlphaGenome 2: Capable of decoding DNA cells with nearly double the mutation identification capacity
Google DeepMind has released its AI model AlphaGenome 2, which is trained on maps of over 100 millions of cells and has nearly double the ability of its predecessor in identifying gene expression variations.

